Literature DB >> 27913648

CD36-Mediated Uptake of Surfactant Lipids by Human Macrophages Promotes Intracellular Growth of Mycobacterium tuberculosis.

Claire E Dodd1,2, Charlie J Pyle2, Rebecca Glowinski2, Murugesan V S Rajaram2, Larry S Schlesinger3,2.   

Abstract

Mycobacterium tuberculosis imposes a large global health burden as the airborne agent of tuberculosis. Mycobacterium tuberculosis has been flourishing in human populations for millennia and is therefore highly adapted to the lung environment. Alveolar macrophages, a major host cell niche for M. tuberculosis, are not only phagocytose inhaled microbes and particulate matter but are also crucial in catabolizing lung surfactant, a lipid-protein complex that lines the alveolar spaces. Because macrophage host defense properties can be regulated by surfactant and M. tuberculosis can use host lipids as a carbon source during infection, we sought to determine the receptor(s) involved in surfactant lipid uptake by human macrophages and whether the presence of those lipids within macrophages prior to infection with M. tuberculosis enhances bacterial growth. We show that preformed scavenger receptor CD36 is redistributed to the cell membrane following exposure to surfactant lipids and surfactant protein A. Subsequently, surfactant lipids and/or surfactant protein A enhance CD36 transcript and protein levels. We show that CD36 participates in surfactant lipid uptake by human macrophages, as CD36 knockdown reduces uptake of dipalmitoylphosphatidylcholine, the most prevalent surfactant lipid species. Finally, exposing human macrophages to surfactant lipids prior to infection augments M. tuberculosis growth in a CD36-dependent manner. Thus, we provide evidence that CD36 mediates surfactant lipid uptake by human macrophages and that M. tuberculosis exploits this function for growth.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27913648      PMCID: PMC5137803          DOI: 10.4049/jimmunol.1600856

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  70 in total

1.  The scavenger receptor CD36 downmodulates the early inflammatory response while enhancing bacterial phagocytosis during pneumococcal pneumonia.

Authors:  Omar Sharif; Ulrich Matt; Simona Saluzzo; Karin Lakovits; Isabella Haslinger; Tanja Furtner; Bianca Doninger; Sylvia Knapp
Journal:  J Immunol       Date:  2013-04-22       Impact factor: 5.422

Review 2.  Macrophage immunoregulatory pathways in tuberculosis.

Authors:  Murugesan V S Rajaram; Bin Ni; Claire E Dodd; Larry S Schlesinger
Journal:  Semin Immunol       Date:  2014-10-30       Impact factor: 11.130

Review 3.  Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle.

Authors:  Debby P Y Koonen; Jan F C Glatz; Arend Bonen; Joost J F P Luiken
Journal:  Biochim Biophys Acta       Date:  2005-10-01

4.  Fatty acid translocase/CD36 mediates the uptake of palmitate by type II pneumocytes.

Authors:  F Guthmann; R Haupt; A C Looman; F Spener; B Rüstow
Journal:  Am J Physiol       Date:  1999-07

5.  Analysis of macrophage scavenger receptor (SR-A) expression in human aortic atherosclerotic lesions.

Authors:  P J Gough; D R Greaves; H Suzuki; T Hakkinen; M O Hiltunen; M Turunen; S Y Herttuala; T Kodama; S Gordon
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

6.  Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responses.

Authors:  Murugesan V S Rajaram; Michelle N Brooks; Jessica D Morris; Jordi B Torrelles; Abul K Azad; Larry S Schlesinger
Journal:  J Immunol       Date:  2010-06-16       Impact factor: 5.422

7.  Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-gamma.

Authors:  Vijaya Nagabhushanam; Alejandra Solache; Li-Min Ting; Claire J Escaron; Jennifer Y Zhang; Joel D Ernst
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

8.  CD36 and TLR interactions in inflammation and phagocytosis: implications for malaria.

Authors:  Laura K Erdman; Gabriela Cosio; Andrew J Helmers; D Channe Gowda; Sergio Grinstein; Kevin C Kain
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

9.  Alveolar macrophage depletion is associated with increased surfactant pool sizes in adult rats.

Authors:  Amy Forbes; Mike Pickell; Mehry Foroughian; Li-Juan Yao; James Lewis; Ruud Veldhuizen
Journal:  J Appl Physiol (1985)       Date:  2007-04-19

Review 10.  Alveolar macrophages: plasticity in a tissue-specific context.

Authors:  Tracy Hussell; Thomas J Bell
Journal:  Nat Rev Immunol       Date:  2014-01-21       Impact factor: 53.106

View more
  26 in total

1.  The novel potential biomarkers for multidrug-resistance tuberculosis using UPLC-Q-TOF-MS.

Authors:  Huai Huang; Yu-Shuai Han; Jing Chen; Li-Ying Shi; Li-Liang Wei; Ting-Ting Jiang; Wen-Jing Yi; Yi Yu; Zhi-Bin Li; Ji-Cheng Li
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-11

Review 2.  Integrating Lung Physiology, Immunology, and Tuberculosis.

Authors:  Jordi B Torrelles; Larry S Schlesinger
Journal:  Trends Microbiol       Date:  2017-03-30       Impact factor: 17.079

Review 3.  Mycobacterium tuberculosis and macrophage nuclear receptors: What we do and don't know.

Authors:  Chrissy M Leopold Wager; Eusondia Arnett; Larry S Schlesinger
Journal:  Tuberculosis (Edinb)       Date:  2019-04-25       Impact factor: 3.131

4.  CISH attenuates homeostatic cytokine signaling to promote lung-specific macrophage programming and function.

Authors:  Karsen E Shoger; Neha Cheemalavagu; Yuqi M Cao; Brandon A Michalides; Virendra K Chaudhri; Jonathan A Cohen; Harinder Singh; Rachel A Gottschalk
Journal:  Sci Signal       Date:  2021-08-31       Impact factor: 8.192

Review 5.  Elemental Ingredients in the Macrophage Cocktail: Role of ZIP8 in Host Response to Mycobacterium tuberculosis.

Authors:  Charlie J Pyle; Abul K Azad; Audrey C Papp; Wolfgang Sadee; Daren L Knoell; Larry S Schlesinger
Journal:  Int J Mol Sci       Date:  2017-11-09       Impact factor: 5.923

6.  Formation of Foamy Macrophages by Tuberculous Pleural Effusions Is Triggered by the Interleukin-10/Signal Transducer and Activator of Transcription 3 Axis through ACAT Upregulation.

Authors:  Melanie Genoula; José Luis Marín Franco; Maeva Dupont; Denise Kviatcovsky; Ayelén Milillo; Pablo Schierloh; Eduardo Jose Moraña; Susana Poggi; Domingo Palmero; Dulce Mata-Espinosa; Erika González-Domínguez; Juan Carlos León Contreras; Paula Barrionuevo; Bárbara Rearte; Marlina Olyissa Córdoba Moreno; Adriana Fontanals; Agostina Crotta Asis; Gabriela Gago; Céline Cougoule; Olivier Neyrolles; Isabelle Maridonneau-Parini; Carmen Sánchez-Torres; Rogelio Hernández-Pando; Christel Vérollet; Geanncarlo Lugo-Villarino; María Del Carmen Sasiain; Luciana Balboa
Journal:  Front Immunol       Date:  2018-03-09       Impact factor: 7.561

Review 7.  Experimental study of tuberculosis: From animal models to complex cell systems and organoids.

Authors:  Kaori L Fonseca; Pedro N S Rodrigues; I Anna S Olsson; Margarida Saraiva
Journal:  PLoS Pathog       Date:  2017-08-17       Impact factor: 6.823

8.  Tuberculosis State Is Associated with Expression of Toll-Like Receptor 2 in Sputum Macrophages.

Authors:  Karim Lakehal; David Levine; Kathleen F Kerr; Pooja Vir; Natalie Bruiners; Alfred Lardizabal; Maria Laura Gennaro; Richard Pine
Journal:  mSphere       Date:  2017-11-01       Impact factor: 4.389

Review 9.  Targeting immunometabolism in host defence against Mycobacterium tuberculosis.

Authors:  Frederick J Sheedy; Maziar Divangahi
Journal:  Immunology       Date:  2020-10-28       Impact factor: 7.397

Review 10.  Underwhelming or Misunderstood? Genetic Variability of Pattern Recognition Receptors in Immune Responses and Resistance to Mycobacterium tuberculosis.

Authors:  Jean-Yves Dubé; Vinicius M Fava; Erwin Schurr; Marcel A Behr
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.